BRIEF-Otsuka, Lundbeck's Abilify Maintena approved in EU

COPENHAGEN Thu Nov 21, 2013 2:16am EST

Related Topics

COPENHAGEN Nov 21 (Reuters) - Danish pharmaceutical company H. Lundbeck A/S said on Thursday: * Once-monthly Abilify Maintena, which is developed in partnership with Japan's Otsuka , has been approved by the European Commision for maintenance treatment of schizophrenia in adult patients stabilized with oral aripiprazole

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.